Authors: Elisa Karhu, MD, MS2; Linda Nguyen, MD3; Sandy Sun, RD4; Christopher Gardner, PhD5
Abstract presented at The American Society for Parenteral and Enteral Nutrition (ASPEN) 2023 Nutrition Science & Practice Conference and published in the supplement of the Journal of Parenteral and Enteral Nutrition (JPEN).
Summary: Adults with gastroparesis were given Kate Farms Peptide 1.5 to supplement their diet with an attempt to determine if improving protein deficit can improve patient symptoms. Weight, GCSI (gastroparesis cardinal symptom index) and PAGI-SYM were measured at baseline, week 4, and week 12.
After 4 weeks of therapy with a liquid nutritional supplement, 100% of patients had a reduction in their gastroparesis symptoms and 75% had a clinically meaningful reduction in their GCSI score (>0.5 reduction).
Use of Kate Farms Peptide 1.5 in adult patients with gastroparesis improved associated symptoms and clinical outcomes (GCSI, % Kcal deficit and % protein deficit).
1. Karhu E, Nguyen L, Sun S, and Gardner C. P51 ‐ The Effect of a Plant‐Based Nutritional Supplement on Symptoms and Calorie‐ and Protein‐Deficits in Patients With Gastroparesis. GI and Other Nutrition and Metabolic-Related Topics Poster Abstracts. ASPEN Nutrition Science & Practice Conference: April 20-23, 2023 (Las Vegas, NV). JPEN J Parenter Enteral Nutr. 2023 April;47(S71-246): S127-128 https://doi.org/10.1002/jpen.2491
2. Stanford University, Palo Alto, California
3. Stanford University, Redwood City, California
4. Stanford Health Care, Redwood City, California
5. Stanford University, Stanford, California